Geoffrey Chang

10.1k total citations · 4 hit papers
52 papers, 6.8k citations indexed

About

Geoffrey Chang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Geoffrey Chang has authored 52 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 24 papers in Oncology and 9 papers in Genetics. Recurrent topics in Geoffrey Chang's work include Drug Transport and Resistance Mechanisms (24 papers), RNA and protein synthesis mechanisms (10 papers) and Bacterial Genetics and Biotechnology (9 papers). Geoffrey Chang is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), RNA and protein synthesis mechanisms (10 papers) and Bacterial Genetics and Biotechnology (9 papers). Geoffrey Chang collaborates with scholars based in United States, Belgium and Japan. Geoffrey Chang's co-authors include Andrew B. Ward, Qinghai Zhang, Ina L. Urbatsch, Douglas C. Rees, Robert H. Spencer, Allen T. Lee, Patina M. Harrell, Rupeng Zhuo, Yue Weng and Stephen G. Aller and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Geoffrey Chang

52 papers receiving 6.7k citations

Hit Papers

Structure of P-Glycoprotein Reveals a Molecular B... 1996 2026 2006 2016 2009 1998 1996 2007 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geoffrey Chang United States 31 4.3k 2.7k 797 685 556 52 6.8k
Ian D. Kerr United Kingdom 37 3.1k 0.7× 1.6k 0.6× 263 0.3× 434 0.6× 212 0.4× 123 4.8k
Ina L. Urbatsch United States 34 2.8k 0.7× 4.1k 1.5× 289 0.4× 1.3k 1.9× 370 0.7× 84 6.1k
Frances J. Sharom Canada 50 4.5k 1.1× 5.2k 1.9× 286 0.4× 1.1k 1.5× 298 0.5× 140 8.7k
Anthony J. Wilkinson United Kingdom 56 7.8k 1.8× 729 0.3× 2.1k 2.7× 650 0.9× 285 0.5× 213 11.0k
David Drew Sweden 37 4.2k 1.0× 784 0.3× 1.4k 1.7× 182 0.3× 213 0.4× 77 5.7k
M.E.M. Noble United Kingdom 63 9.9k 2.3× 2.9k 1.1× 631 0.8× 537 0.8× 156 0.3× 144 13.7k
A. Teplyakov United States 37 8.5k 2.0× 1.0k 0.4× 1.1k 1.4× 581 0.8× 262 0.5× 100 11.7k
Ming‐Daw Tsai United States 51 7.5k 1.8× 1.1k 0.4× 1.2k 1.5× 427 0.6× 166 0.3× 292 10.1k
W.F. Anderson United States 53 6.7k 1.6× 742 0.3× 2.7k 3.3× 480 0.7× 215 0.4× 217 9.5k
Simon Newstead United Kingdom 40 3.6k 0.8× 871 0.3× 632 0.8× 172 0.3× 139 0.3× 84 5.3k

Countries citing papers authored by Geoffrey Chang

Since Specialization
Citations

This map shows the geographic impact of Geoffrey Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Chang more than expected).

Fields of papers citing papers by Geoffrey Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Chang. The network helps show where Geoffrey Chang may publish in the future.

Co-authorship network of co-authors of Geoffrey Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Chang. A scholar is included among the top collaborators of Geoffrey Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Chang. Geoffrey Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Geoffrey, et al.. (2023). Probing the proteome of mpox virus for in silico design of a multiepitope vaccine. 5(4). 1 indexed citations
2.
Granados, Jeffry C., et al.. (2023). The kidney drug transporter OAT1 regulates gut microbiome–dependent host metabolism. JCI Insight. 8(2). 14 indexed citations
3.
Maity, Koustav, John M. Heumann, Aaron P. McGrath, et al.. (2019). Cryo-EM structure of OSCA1.2 from Oryza sativa elucidates the mechanical basis of potential membrane hyperosmolality gating. Proceedings of the National Academy of Sciences. 116(28). 14309–14318. 82 indexed citations
4.
Zaramela, Lívia S., Cameron Martino, Frederico Alisson‐Silva, et al.. (2019). Gut bacteria responding to dietary change encode sialidases that exhibit preference for red meat-associated carbohydrates. Nature Microbiology. 4(12). 2082–2089. 65 indexed citations
5.
Schrankel, Catherine S., Tufan Gökirmak, Chang‐Wook Lee, Geoffrey Chang, & Amro Hamdoun. (2019). Generation, expression and utilization of single-domain antibodies for in vivo protein localization and manipulation in sea urchin embryos. Methods in cell biology. 151. 353–376. 5 indexed citations
7.
Moeller, Arne, Sung Chang Lee, Houchao Tao, et al.. (2015). Distinct Conformational Spectrum of Homologous Multidrug ABC Transporters. Structure. 23(3). 450–460. 89 indexed citations
8.
Zhang, Xiaohong, Xiao He, Joseph L. Baker, et al.. (2012). Twelve Transmembrane Helices Form the Functional Core of Mammalian MATE1 (Multidrug and Toxin Extruder 1) Protein. Journal of Biological Chemistry. 287(33). 27971–27982. 34 indexed citations
9.
Tao, Houchao, Yue Weng, Rupeng Zhuo, et al.. (2011). Design and Synthesis of Selenazole‐Containing Peptides for Cocrystallization with P‐Glycoprotein. ChemBioChem. 12(6). 868–873. 19 indexed citations
10.
Gutmann, Daniel A.P., Andrew B. Ward, Ina L. Urbatsch, Geoffrey Chang, & Hendrik W. van Veen. (2009). Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. Trends in Biochemical Sciences. 35(1). 36–42. 118 indexed citations
11.
Ward, Andrew B., et al.. (2008). Nucleotide dependent packing differences in helical crystals of the ABC transporter MsbA. Journal of Structural Biology. 165(3). 169–175. 23 indexed citations
12.
Zhang, Qinghai, Xingquan Ma, Andrew B. Ward, et al.. (2007). Designing Facial Amphiphiles for the Stabilization of Integral Membrane Proteins. Angewandte Chemie International Edition. 46(37). 7023–7025. 104 indexed citations
13.
Yin, Yong, et al.. (2006). Structure of the Multidrug Transporter EmrD from Escherichia coli. Science. 312(5774). 741–744. 317 indexed citations
14.
15.
Katzen, Federico, Geoffrey Chang, & Wieslaw Kudlicki. (2005). The past, present and future of cell-free protein synthesis. Trends in biotechnology. 23(3). 150–156. 256 indexed citations
16.
Reyes, C., et al.. (2005). The structures of MsbA: Insight into ABC transporter‐mediated multidrug efflux. FEBS Letters. 580(4). 1042–1048. 32 indexed citations
17.
Ma, Che & Geoffrey Chang. (2004). Crystallography of the integral membrane protein EmrE fromEscherichia coli. Acta Crystallographica Section D Biological Crystallography. 60(12). 2399–2402. 5 indexed citations
18.
Chang, Geoffrey. (2003). Multidrug resistance ABC transporters. FEBS Letters. 555(1). 102–105. 142 indexed citations
19.
Spencer, Richard G., Geoffrey Chang, & Douglas C. Rees. (1999). ‘Feeling the pressure’: structural insights into a gated mechanosensitive channel. Current Opinion in Structural Biology. 9(4). 448–454. 41 indexed citations
20.
Lewis, Mitchell, Geoffrey Chang, Nancy C. Horton, et al.. (1996). Crystal Structure of the Lactose Operon Repressor and Its Complexes with DNA and Inducer. Science. 271(5253). 1247–1254. 636 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026